[Correspondence] Universal testing of cutaneous sebaceous carcinoma: a missed opportunity in Lynch syndrome detection

January, 01, 2024 | Select Oncology Journal Articles

Lynch syndrome detection in patients with cancer has immediate implications for therapy, cancer surveillance, genetic counselling, and chemoprevention with aspirin.1 Although all new diagnoses of colorectal and endometrial cancers in the UK are recommended by the National Institute for Health and Care Excellence (NICE) to undergo diagnostic testing for Lynch syndrome, many less commonly diagnosed Lynch syndrome spectrum cancers, including skin cancers such as sebaceous carcinoma,2 are not automatically tested, which results in missed opportunities for improved care in affected patients and their families.

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –




Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy